OBJECTIVE: The present study sought to replicate previous findings of an association between the Catechol-O-methyltransferase (COMT) val158met polymorphism with posttraumatic stress disorder (PTSD) and symptomatology in a novel age group, preschool children. METHODS: COMT genotype was determined in a sample of 171 3-6-year-old trauma-exposed children. PTSD was assessed with a semistructured interview. Accounting for sex, trauma type, and age, genotype was examined in relation to categorical and continuous measures of PTSD both controlling for race and within the two largest racial categories (African American [AA] and European American [EA]). RESULTS: Race significantly moderated the association between genotype and PTSD. Specifically, the genotype associated with increased PTSD symptoms in one racial group had the opposite association in the other racial group. For AA children the met/met genotype was associated with more PTSD symptoms. However, for EA children, val allele carriers had more PTSD symptoms. Whereas every AA child with the met/met genotype met criteria for PTSD, none of the EA children with the met/met genotype did. This genetic association with COMT genotype, in both races but in opposite directions, was most associated with increased arousal symptoms. CONCLUSIONS: These findings replicate previous findings in participants of African descent, highlight the moderating effect of race on the association between COMT genotype and PTSD, and provide direct evidence that consideration of population stratification within gene-by-environment studies is valuable to prevent false negative findings.
OBJECTIVE: The present study sought to replicate previous findings of an association between the Catechol-O-methyltransferase (COMT) val158met polymorphism with posttraumatic stress disorder (PTSD) and symptomatology in a novel age group, preschool children. METHODS:COMT genotype was determined in a sample of 171 3-6-year-old trauma-exposed children. PTSD was assessed with a semistructured interview. Accounting for sex, trauma type, and age, genotype was examined in relation to categorical and continuous measures of PTSD both controlling for race and within the two largest racial categories (African American [AA] and European American [EA]). RESULTS: Race significantly moderated the association between genotype and PTSD. Specifically, the genotype associated with increased PTSD symptoms in one racial group had the opposite association in the other racial group. For AA children the met/met genotype was associated with more PTSD symptoms. However, for EA children, val allele carriers had more PTSD symptoms. Whereas every AA child with the met/met genotype met criteria for PTSD, none of the EA children with the met/met genotype did. This genetic association with COMT genotype, in both races but in opposite directions, was most associated with increased arousal symptoms. CONCLUSIONS: These findings replicate previous findings in participants of African descent, highlight the moderating effect of race on the association between COMT genotype and PTSD, and provide direct evidence that consideration of population stratification within gene-by-environment studies is valuable to prevent false negative findings.
Authors: Michael S Scheeringa; Charles H Zeanah; Leann Myers; Frank W Putnam Journal: J Am Acad Child Adolesc Psychiatry Date: 2003-05 Impact factor: 8.829
Authors: Hua Tang; Tom Quertermous; Beatriz Rodriguez; Sharon L R Kardia; Xiaofeng Zhu; Andrew Brown; James S Pankow; Michael A Province; Steven C Hunt; Eric Boerwinkle; Nicholas J Schork; Neil J Risch Journal: Am J Hum Genet Date: 2004-12-29 Impact factor: 11.025
Authors: R H Segman; R Cooper-Kazaz; F Macciardi; T Goltser; Y Halfon; T Dobroborski; A Y Shalev Journal: Mol Psychiatry Date: 2002 Impact factor: 15.992
Authors: D Scheggia; E Zamberletti; N Realini; M Mereu; G Contarini; V Ferretti; F Managò; G Margiani; R Brunoro; T Rubino; M A De Luca; D Piomelli; D Parolaro; F Papaleo Journal: Mol Psychiatry Date: 2017-06-20 Impact factor: 15.992
Authors: Kenneth Blum; M C Gondré-Lewis; E J Modestino; L Lott; D Baron; D Siwicki; T McLaughlin; A Howeedy; M H Krengel; M Oscar-Berman; P K Thanos; I Elman; M Hauser; L Fried; A Bowirrat; R D Badgaiyan Journal: Mol Neurobiol Date: 2019-05-23 Impact factor: 5.590
Authors: Ethan A Winkler; John K Yue; Adam R Ferguson; Nancy R Temkin; Murray B Stein; Jason Barber; Esther L Yuh; Sourabh Sharma; Gabriela G Satris; Thomas W McAllister; Jonathan Rosand; Marco D Sorani; Hester F Lingsma; Phiroz E Tarapore; Esteban G Burchard; Donglei Hu; Celeste Eng; Kevin K W Wang; Pratik Mukherjee; David O Okonkwo; Ramon Diaz-Arrastia; Geoffrey T Manley Journal: J Clin Neurosci Date: 2016-10-18 Impact factor: 1.961
Authors: Claire J Han; Ruth Kohen; Sangeun Jun; Monica E Jarrett; Kevin C Cain; Robert Burr; Margaret M Heitkemper Journal: Nurs Res Date: 2017 Mar/Apr Impact factor: 2.381
Authors: Kristen R Weaver; Maja Mustapic; Dimitrios Kapogiannis; Wendy A Henderson Journal: Neurogastroenterol Motil Date: 2021-09-09 Impact factor: 3.960
Authors: Janitza L Montalvo-Ortiz; Joel Gelernter; James Hudziak; Joan Kaufman Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2015-11-22 Impact factor: 3.568
Authors: Christopher W Jones; Sarah A O Gray; Katherine P Theall; Stacy S Drury Journal: Psychoneuroendocrinology Date: 2018-06-25 Impact factor: 4.905